Ottevanger Petronella B - European Org Res & Treatment Canc, Radboud Univ Nijmegen

基本信息

浏览量：145

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 212 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Clinical Research in Endometrial Cancer: Consensus Recommendations from the Gynecologic Cancer InterGroup

Carien L Creutzberg, Jae-Weon Kim,Gemma Eminowicz, Emma Allanson,Lauriane Eberst,Se Ik Kim, Remi A Nout, Jeong-Yeol Park,Domenica Lorusso,Linda Mileshkin,Petronella B Ottevanger,Alison Brand,Delia Mezzanzanica,Amit Oza,Val Gebski,Bhavana Pothuri, Tania Batley, Carol Gordon, Tina Mitra,Helen White

The Lancet Oncologyno. 9 (2024): e420-e431

引用0浏览0WOS引用

1197P Ex Vivo Basket Study Reports Patient-Specific Sensitivity to Carboplatin Versus Cisplatin in Lung, Ovarian and Bladder Cancer

D. Robbrecht, E. Koedoot,D. van der Meer, L.J. Ceton, T. Sijsenaar,W. Vader,L. Steinbusch,C. Steendam,J. Boormans,P.B. Ottevanger

Annals of Oncology（2024）

引用0浏览0引用

Dendritic Cell Vaccination Combined with Carboplatin/paclitaxel for Metastatic Endometrial Cancer Patients: Results of a Phase I/II Trial

Bouke J. Koeneman,Gerty Schreibelt,Mark A. J. Gorris,Simone Hins-de Bree,Harm Westdorp,Petronella B. Ottevanger,I. Jolanda M. de Vries

FRONTIERS IN IMMUNOLOGY (2024)

引用0浏览0WOS引用

Garcia,Toon Van Gorp,Gottfried E Konecny,Alexandra Leary,Alessandro D Santin, Shanthini Mary Crusz,Gina Mantia-Smaldone,Domenica Lorusso,Nicoletta Colombo,Jessica Thomes-Pepin,Andrzej Roszak,Petronella B Ottevanger,Mario Beiner,David Cibula,Charles Leath, Lingling Li,Michael Method,Kathleen N Moore

Oral Sessions (2024)

引用0浏览0引用

Potential Adverse Outcomes of Shared Decision Making about Palliative Cancer Treatment: A Secondary Analysis of a Randomized Trial

Lois F. van de Water,Danique W. Bos-van den Hoek,Steven C. Kuijper,Hanneke W. M. van Laarhoven,Geert-Jan Creemers,Serge E. Dohmen,Helle-Brit Fiebrich,Petronella B. Ottevanger,Dirkje W. Sommeijer,Filip Y. F. de Vos,Ellen M. A. Smets,Inge Henselmans

MEDICAL DECISION MAKINGno. 1 (2024): 89-101

引用0浏览0WOS引用

Combination of Cemiplimab and ISA101b Vaccine for the Treatment of Recurrent/metastatic HPV16 Cervical Cancer

Domenica Lorusso,Ana Oaknin,Giuliano Santos Borges,Fernanda Damian,P. B. Ottevanger,Toon Van Gorp, Carlos Eduardo Paiva,Judith R. Kroep,Yong Man Kim,Hee Seung Kim,Jae-Kwan Lee,Cornelis J. M. Melief,Leon Hooftman, Jamil,Suk-Young Yoo,Frank A. Seebach,Israel Lowy,Matthew G. Fury,Melissa Divya Mathias,Nicoletta Colombo

Journal of Clinical Oncologyno. 16_suppl (2024): 5522-5522

引用0浏览0引用

PAZEC: a Dutch Gynaecological Oncology Group Open-Label, Multicenter, Phase II Study of Pazopanib in Metastatic and Locally Advanced Hormone-Resistant Endometrial Cancer

Anneke Westermann,Petronella Ottevanger,An Reyners,Judith R. Kroep,Martijn G. H. Van Oijen,Roy Lalisang,Petronella O. Witteveen

International Journal of Gynecological Cancerno. 2 (2024): 239-243

引用0浏览0WOS引用

The potential of RAS/RAF/MEK/ERK (MAPK) signaling pathway inhibitors in ovarian cancer: A systematic review and meta-analysis

C S E Hendrikse, P M M Theelen, P van der Ploeg,H M Westgeest,I A Boere,A M J Thijs,P B Ottevanger,A van de Stolpe,S Lambrechts,R L M Bekkers,J M J Piek

Gynecologic oncology（2023）

引用5浏览0WOS引用

769P Pharmacokinetic Boosting of Olaparib: an Open-Label, Prospective, Cross-over Study

J. Overbeek, N. Guchelaar, M. I. Mohmaed Ali,P. B. Ottevanger,H. Bloemendal,S. Koolen,R. Mathijssen,I. Boere,P. Hamberg,A. Huitema,G. Sonke,F. Opdam,R. Ter Heine,N. Van Erp

Annals of Oncology (2023): S522-S522

引用0浏览0引用

The potential of RAS/RAF/MEK/ERK (MAPK) signaling pathway inhibitors in ovarian cancer: A systematic review and meta-analysis

C. S. E. Hendrikse, P. M. M. Theelen, P. van der Ploeg,H. M. Westgeest,I. A. Boere,A. M. J. Thijs,P. B. Ottevanger,A. van de Stolpe,S. Lambrechts,R. L. M. Bekkers,J. M. J. Piek

GYNECOLOGIC ONCOLOGY (2023): 83-94

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn